An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer Patients

The clinical applicability of the whole-exome sequencing (WES) in estimating tumor mutational burden (TMB) is currently limited by high cost, time-consuming and tissue availability. And given to the differences in the mutational landscapes among different types of cancer, we aimed to develop a cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Wenbing, Fu, Yelin, Jin, Liangliang, Song, Kai, Yu, Ruihan, Li, Tianhao, Qi, Lishuang, Gu, Yunyan, Zhao, Wenyuan, Guo, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959028/
https://www.ncbi.nlm.nih.gov/pubmed/31949492
http://dx.doi.org/10.7150/jca.34363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959028/
https://www.ncbi.nlm.nih.gov/pubmed/31949492
http://dx.doi.org/10.7150/jca.34363

Ejemplares similares